SPL UNCLASSIFIED SECTION
Drug Facts
Drug Facts
Active Ingredients:
Menthol 4%
Lidocaine 4%
Purpose:
Menthol ....................Topical Analgesic
Lidocaine ..................Topical Anisthetic
Uses:
Temporarily relieves minor aches and muscle pains associated with
arthritis, simple backache, strains, muscle soreness and stiffness.
Warnings
• For external use only. Use only as directed by your healthcare
professional.
• Do not use: On open wounds, cuts, damaged or infevted skin, or in the
eyes, mouth, genitals, or or any other mucus membrane.
• Do not cover with tape or bandage.
• Keep out of reach of children. Consult physician for children under 12.
• Consult your physician if pregnant or pain persists or worsens.
Directions:
Adults and children 12 years and over: Apply patch to affected area 1
to 2 times daily or as directed.
Instructions for use:
• Clean and dry the affected area
• Open one single-use pouch
• Remove patch and then remove clear film from patch surface
• Apply patch directly to the affected area of pain
• Wash hands with soap and water ater applyinfg patch
Other Ingredients:
Presure Sensitive Adhesive, Cannabidiol (Hemp Extract), Diethylene
Glycol Monoethyl Ether, Vitamin C [as Ascorbyl Palmitate]
NEOLINN
TOPICAL PAIN PATCH
Lidocaine 4% Qty: 30 Patches
Menthol 4% Individually Packaged
Single Use
Lot# NDC 81816-001-30
Exp. Date
Store in a dry, cool place.
For comments or questions, contact us at: support@neolinn.com
Manufactured for Neolinn, LLC by Remy Biosciences
17802 Sky Park Circle
Ste. 100
Irvine, CA 92614
Box
Pouch
res
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| 4d7a96d5-8256-4268-9a6c-25ea66d321fe | Product name | 1 | 20180814 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81816-001-30 | 2023-01-30 | C162847 | 48780-1 | f386c649-e4d3-0266-e053-dadaa90a7c1a | NEOLINN Topical Pain Patch |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81816-001-01 | NEOLINN | 300 mg in 1 PATCH | PATCH | 300 | 1 | |
| 81816-001-01 | NEOLINN | 1 in 1 POUCH | PATCH | 1 | 1 | |
| 81816-001-30 | NEOLINN | 30 in 1 BOX | PATCH | 30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 81816-001 | 81816-001-01, 81816-001-30 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 41511577-63e8-4773-a114-891e2caa95dd | 562b5a21-d304-41d4-a52b-f12899daeecb | 2021-06-02 | Warnings | 41511577-63e8-4773-a114-891e2caa95dd 562b5a21-d304-41d4-a52b-f12899daeecb |
Adverse event summaries are temporarily unavailable. Other product information remains available.